glp-1 cardiovascular outcomes 2025 news Glucagon-like peptide 1 receptor agonists: benefits and mechanisms of action GLP-1 Agonists in Cardiovascular Diseases:

While weight-loss medications offer significant benefits for many patients, experts say maintaining body weight and muscle mass remains an important consideration for people with neurodegenerative diseases

- GLP-1 GIP 23 10% NEAT 1.21.6 23 NEAT 5% GLP-1 GIP 72 15%~20% 2~4 24 72 15%20% GLP-1 GIP GLP-1 Tirzepatide 59 GLP-1 GIP 13% 4 HIIT BMI GLP-1 2026GLP-1 2025Wegovy GLP-1 GLP-1Q&A 2025 WegovyGLP-1

Patients with a history of small-bowel obstruction or fistulizing disease should consult their gastroenterologist before initiating any GLP-1, as slowed gastric emptying and reduced motility may pose mechanical risks

When the GLP-1 signal is removed, the animals are prone to drinking more alcohol